definiens: herein means [ * * * ] ; andfor the avoidance of doubt, Company agrees that this Section 10.4(a ) shall not be interpreted so as to prohibit the owners of mRNARiboTherapeutics and/or [COMPANY] from proposing or discussing [ * * * ] ; ( c ) the purchaser of mRNA RiboTherapeutics or [COMPANY], respectively, will pay [ * * * ] ; ( d ) on the effective date of any such sale of [ * * * ] and the purchaser and their assignees and successors in ownership thereof shall haveall the same rights as are held by Company under this Agreement to : ( i)grant Human In Vivo Therapeutics Field Sublicenses to affiliates and Third Parties without being subject to any restrictions, limitations, or terms and conditions that apply to the Primary Sublicensors under Sections 10.2, and ( ii)grant Product Sublicenses to affiliates and any Third Parties to research, develop, manufacture and/or commercialize anynumber of products comprising modified RNA covered by Patent Rights for any therapeutic or prophylactic use in humans in theIn Vivo Field of Use without being subject to any of the restrictions, limitations or requirements that the sublicensee is a SmallBiotech Company as is required of the Primary Sublicensors in Section 10.3 ; and(e ) on the effective date of any such sale of more than fifty percent ( 50 % ) of the outstanding stock or ownership interest or all of thebusiness or assets of mRNA RiboTherapeutics or [COMPANY], all of the rights of the Primary Sublicensors to grant Product Sublicensespursuant to Section 10.3 shall remain only with the Primary Sublicensors for which their stock, ownership interest, business and assets werenot sold